Literature DB >> 23955064

Biomarkers in ANCA-associated vasculitis.

Lindsay Lally1, Robert F Spiera.   

Abstract

Despite recent advances in the treatment of antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV), relapse remains common and patients often experience a variable clinical course after initial treatment. New biomarkers are needed to aid the management of these complex diseases. Discoveries regarding the pathogenesis of AAV, from the importance both of activated B and T cells and the alternative complement pathway to genomic data, may lay the groundwork for identification of novel biomarkers.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23955064     DOI： 10.1007/s11926-013-0363-x

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


  39 in total

1.  Are antineutrophil cytoplasmic antibodies a marker predictive of relapse in Wegener's granulomatosis? A prospective study.

Authors:  T Girard; A Mahr; L H Noël; J F Cordier; P Lesavre; M H André; L Guillevin
Journal:  Rheumatology (Oxford)       Date:  2001-02       Impact factor: 7.580

2.  Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis--a meta-analysis.

Authors:  Gunnar Tomasson; Peter C Grayson; Alfred D Mahr; Michael Lavalley; Peter A Merkel
Journal:  Rheumatology (Oxford)       Date:  2011-10-29       Impact factor: 7.580

3.  urinary biomarkers in relapsing antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Jason G Lieberthal; David Cuthbertson; Simon Carette; Gary S Hoffman; Nader A Khalidi; Curry L Koening; Carol A Langford; Kathleen Maksimowicz-McKinnon; Philip Seo; Ulrich Specks; Steven R Ytterberg; Peter A Merkel; Paul A Monach
Journal:  J Rheumatol       Date:  2013-04-01       Impact factor: 4.666

4.  Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center.

Authors:  Rodrigo Cartin-Ceba; Jason M Golbin; Karina A Keogh; Tobias Peikert; Marta Sánchez-Menéndez; Steven R Ytterberg; Fernando C Fervenza; Ulrich Specks
Journal:  Arthritis Rheum       Date:  2012-11

5.  Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis.

Authors:  Sophia Lionaki; Elizabeth R Blyth; Susan L Hogan; Yichun Hu; Brent A Senior; Caroline E Jennette; Patrick H Nachman; J Charles Jennette; Ronald J Falk
Journal:  Arthritis Rheum       Date:  2012-10

6.  Use of highly sensitive C-reactive protein for followup of Wegener's granulomatosis.

Authors:  Anna-Isabelle Kälsch; Elena Csernok; Dominik Münch; Rainer Birck; Benito A Yard; Wolfgang Gross; Thorsten Kälsch; Wilhelm H Schmitt
Journal:  J Rheumatol       Date:  2010-08-17       Impact factor: 4.666

7.  C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis.

Authors:  Adrian Schreiber; Hong Xiao; J Charles Jennette; Wolfgang Schneider; Friedrich C Luft; Ralph Kettritz
Journal:  J Am Soc Nephrol       Date:  2008-12-10       Impact factor: 10.121

Review 8.  T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells?

Authors:  Benjamin Wilde; Marielle Thewissen; Jan Damoiseaux; Pieter van Paassen; Oliver Witzke; Jan Willem Cohen Tervaert
Journal:  Arthritis Res Ther       Date:  2010-02-24       Impact factor: 5.156

9.  A CD8+ T cell transcription signature predicts prognosis in autoimmune disease.

Authors:  Eoin F McKinney; Paul A Lyons; Edward J Carr; Jane L Hollis; David R W Jayne; Lisa C Willcocks; Maria Koukoulaki; Alvis Brazma; Vojislav Jovanovic; D Michael Kemeny; Andrew J Pollard; Paul A Macary; Afzal N Chaudhry; Kenneth G C Smith
Journal:  Nat Med       Date:  2010-04-18       Impact factor: 53.440

10.  Monocyte chemoattractant protein 1 is a prognostic marker in ANCA-associated small vessel vasculitis.

Authors:  Sophie Ohlsson; Omran Bakoush; Jan Tencer; Ole Torffvit; Mårten Segelmark
Journal:  Mediators Inflamm       Date:  2009-07-05       Impact factor: 4.711
View more
  4 in total

Review 1.  New insights on biomarkers in systemic vasculitis.

Authors:  Rodolfo Perez-Alamino; Hernán Maldonado-Ficco
Journal:  Curr Rheumatol Rep       Date:  2015-03       Impact factor: 4.592

2.  Serum chitinase-3-like 1 protein is a useful biomarker to assess disease activity in ANCA-associated vasculitis: an observational study.

Authors:  Sung Soo Ahn; Taejun Yoon; Yong-Beom Park; Maria Prendecki; Gurjeet Bhangal; Stephen P McAdoo; Sang-Won Lee
Journal:  Arthritis Res Ther       Date:  2021-03-08       Impact factor: 5.156

Review 3.  Serological Biomarkers and Indices for the Current Activity and Prognosis of ANCA-Associated Vasculitis: Experience in a Single Centre in Korea.

Authors:  Sung Soo Ahn; Yong Beom Park; Sang Won Lee
Journal:  Yonsei Med J       Date:  2021-04       Impact factor: 2.759

4.  Peripheral blood natural killer cell percentages in granulomatosis with polyangiitis correlate with disease inactivity and stage.

Authors:  Wolfgang Merkt; Prisca Sturm; Felix Lasitschka; Theresa Tretter; Carsten Watzl; Daniel Saure; Michael Hundemer; Vedat Schwenger; Norbert Blank; Hanns-Martin Lorenz; Adelheid Cerwenka
Journal:  Arthritis Res Ther       Date:  2015-11-21       Impact factor: 5.156
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.